Concepedia

Phase III trial comparing 3–6 months of adjuvant FOLFOX4/XELOX in stage II–III colon cancer: safety and compliance in the TOSCA trial

Sara Lonardi, Alberto Sobrero, Gerardo Rosati, Maria Di Bartolomeo, Monica Ronzoni, Giuseppe Aprile, Mario Scartozzi, Maria Banzi, Maria Giulia Zampino, Felice Pasini,

Annals of Oncology · 2016 · 56 citations · 10 references

DOIFull text

Open access

Concepts

References

10

The National Comprehensive Cancer Network

William T. McGivney · Cancer · 1998 · 16.9K citations

, , +15

Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

Thierry André, C. Boni, Matilde Navarro et al. · Journal of Clinical Oncology · 2009 · 2.3K citations

, , +16

Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Roberto Labianca, Bernard Nordlinger, Giordano Beretta et al. · Annals of Oncology · 2013 · 1.4K citations · Full text

, , +14

Efficacy of adjuvant fluorouracil and folinic acid in colon cancer

The Lancet · 1995 · 1.1K citations

, , +15

OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR Study

Christophe Tournigand, Andrés Cervantes, Arié Figer et al. · Journal of Clinical Oncology · 2006 · 805 citations

, , +15